As a leading global provider of biospecimens and value-added services, BioIVT understands your needs when it comes to brain cancer-related specimens. With the ability to ethically collect diseased biospecimens as well as donor-matched and control true normal biospecimens, as well as the ability to customize collections to fit-for-purpose use, BioIVT is your partner in ELEVATING SCIENCE.
BioIVT’s clinical specimens now include the ASTERAND Human Tissue Specimens and include brain cancer collected as surgical discards, while biofluids include blood-derived as well as other biofluids. Matched biofluids are available for select cases. With board-certified pathological confirmation of disease and correlation with clinical staging, matched with the ability to designate specific inclusion/exclusion criteria related to stage, treatment, race/ethnicity, age, relevant mutation status, comorbidities and outcome, you know the specimen you are working with is exactly the specimen your research requires.